Trial reportFrontiers in public health2026
Effect of a mobile application-based whole-course nutrition management intervention in patients with age-related macular degeneration: a randomized controlled trial.
Trial report in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aims and objectives: Evaluate the effect of the application (APP)-based AIM-AMD (Assessment, Introduction, Management, and App-based Maintenance Dynamically) nutrition management model in patients with age-related macular degeneration (AMD). Background: Nutritional intervention are one of the only ways to prevent the development of AMD and slow its progression. However, poor compliance with patient nutritional management leads to ineffective nutritional supplementation outcomes. Design: A randomised controlled trial was conducted from October 2023-January 2024 and performed according to the CONSORT guidelines. Methods: A total of 140 participants were randomly assigned to the intervention or control group. The intervention was administered three times per week for a period of 3 months. The intervention group was adopted with APP-based AIM-AMD nutrition management + routine nursing, while the control group was adopted with routine nursing. Comparison was conducted on the effects of different programs on AMD patient nutrient intake, nutrition knowledge, vision-related quality of life, self-efficacy and best-corrected visual acuity (BCVA) at the beginning and at the end of the intervention (Clinical Trials.gov: ChiCTR2200063978). Results: The results indicated that the intake of energy, zinc, copper, calcium, vitamin C, vitamin E and lutein was significantly higher in the intervention group than in the control group ( Conclusion: Our research demonstrates that the APP-based AIM-AMD nutrition management model offers patients comprehensive, accurate, and personalized guidance on dietary management. Relevance to clinical practice: The results of this study demonstrate that the AIM-AMD nutritional management model holds demonstrable clinical value in the nutritional management process of patients with AMD. Clinical trial registration: https://www.chictr.org.cn/showproj.html?proj=175931, Identifier ChiCTR2200063978.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.